Obstructive vs Non-Obstructive HCM in Cats: Why the Difference Decides the Treatment

Short answer: in every cat with HCM the heart muscle thickens — but in roughly a third to a half, the thickened wall and a displaced mitral valve also narrow the heart's exit while it contracts. That is obstructive HCM, and the distinction is not academic: it changes what the murmur means, it can change symptoms and management, and as of this decade it decides which disease-directed therapies even apply to your cat. The two forms are told apart one way only: echocardiography.

What "obstruction" physically is

Blood leaves the left ventricle through the outflow tract, a corridor between the septum and the mitral valve. In obstructive HCM two things go wrong at once: the thickened septum bulges into that corridor, and the mitral valve gets pulled toward it during contraction — a phenomenon called SAM, systolic anterior motion. The corridor pinches exactly when blood is trying to pass. The heart responds by squeezing harder, which worsens the pinch: a self-tightening loop, repeated every beat.

Non-obstructive HCM has the same thickened, stiff muscle — the same impaired filling, the same atrial enlargement and clot risk over time — without the exit narrowing.

How the echo tells them apart

The cardiologist looks for SAM, measures flow speed through the outflow tract, and derives a pressure gradient — the higher the speed, the tighter the pinch. Obstruction can be dynamic: mild at rest, pronounced under stress or a fast heart rate, which is one reason a single resting scan sometimes understates it, and why serial echoes matter.

A practical note on murmurs: obstructive cats usually have loud ones (turbulent flow through a pinched exit is noisy), while non-obstructive cats may have none at all. This is why a murmur is neither proof nor exclusion of anything — our murmur guide covers that trap.

Does obstruction change the outlook?

Course and outlook in HCM are individual in both forms; large feline studies have not made obstruction a simple verdict, and non-obstructive cats can progress seriously too. What obstruction unambiguously changes is management: it adds a mechanical problem that now, for the first time, has a therapy class aimed straight at it.

Which therapies map to which form

• Both forms share the fundamentals: staging echoes, clot prevention where the atrium enlarges, heart-failure care if decompensation comes — the full map is in our treatment guide.
• Subclinical disease of either form is where rapamycin is studied, aimed at slowing the wall-thickening process itself (evidence guide).
• The obstructive form specifically is where mavacamten applies — a myosin inhibitor that eases the excessive contraction driving the pinch, approved for this exact problem in human medicine and investigational in cats (what it is; Mavacor, our therapy). It has no role in non-obstructive cats, and a cat with weakened systolic function must not receive it.

What to ask after an HCM diagnosis

Three questions turn a frightening word into a plan: Is it obstructive? How large is the left atrium? — that is the clot-risk question — and What monitoring interval fits this stage? The first answer sorts every therapy conversation that follows.

The honest summary

Same name, two mechanically different diseases. Non-obstructive HCM is a stiff-muscle problem; obstructive HCM is a stiff-muscle problem plus a pinched exit. The pinch is measurable, it is dynamic, and it is now the specific target of an entire drug class. Which side of the line your cat is on is one echocardiogram away — and it is the single most useful fact an owner of an HCM cat can know.